ENTITY

Forty Seven Inc (FTSV US)

4
Analysis
Health CareUnited States
Forty Seven, Inc. operates as a clinical-stage immuno-oncology company. The Company develops novel checkpoint therapies to activate macrophages targeting cancer immune evasion pathways. Forty Seven serves customers in the State of California.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x